NG

Niladry Ganguly

Active Director Director DIN 11821357
DIN 11821357 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Niladry Ganguly

Niladry Ganguly is a Director at Holy Cross Pharmaceuticals Private Limited (since 2026).

DIN 11821357
Primary Designation Director
First Appointment 13 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jul 20262026Active

Board colleagues of Niladry Ganguly

Directorship timeline

Open interactive timeline →
Holy Cross Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Niladry Ganguly

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Niladry Ganguly

Niladry Ganguly currently holds 1 directorship: Holy Cross Pharmaceuticals Private Limited (Director, since 13 Jul 2026).

Niladry Ganguly was first appointed on 13 Jul 2026 as Director at Holy Cross Pharmaceuticals Private Limited.

The current boards of Niladry Ganguly's companies include Debasis Ganguly (Holy Cross Pharmaceuticals Private Limited), Joyanta Ganguly (Holy Cross Pharmaceuticals Private Limited), Mallika Ganguly (Holy Cross Pharmaceuticals Private Limited), Prasanta Sekhar Ganguly (Holy Cross Pharmaceuticals Private Limited), Shibani Ganguly (Holy Cross Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available